By Sheri Kasprzak
Atlanta, Dec. 16 - Resverlogix Corp. said Thursday it plans to raise C$3,081,099 in a private placement.
The company will sell 1,027,033 shares, which are remaining from a previously announced private placement, at C$3 each.
Resverlogix closed a downsized C$7.9 million offering on Nov. 23. The deal originally called for 3 million shares at C$3 each. The company actually sold 2,639,633 of the shares. The deal, first announced Oct. 6 as a C$9 million offering, had an option for an additional C$2 million in shares.
First Associates Investments Inc. was lead underwriter in a syndicate that included Haywood Securities Inc., Loewen Ondaatje McCutcheon Ltd., Sprott Securities Inc. and Jennings Capital Inc.
Resverlogix, based in Calgary, Alta., is a biotechnology company focused on the development of biopharmaceuticals.
| Issuer: | Resverlogix Corp.
|
| Issue: | Stock
|
| Amount: | C$3,081,099
|
| Shares: | 1,027,033
|
| Price: | C$3.00
|
| Warrants: | No
|
| Underwriters: | First Associates Investments Inc. (lead); Haywood Securities Inc.; Loewen Ondaatje McCutcheon Ltd.; Sprott Securities Inc. and Jennings Capital Inc.
|
| Announcement date: | Dec. 16
|
| Stock price: | C$3.35 at close Dec. 16
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
